EchoGo® Heart Failure vs Tempus ECG-Low EF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent competitors, as both leverage AI to assist in heart failure diagnosis but utilize different input modalities. EchoGo® Heart Failure analyzes echocardiograms to detect HFpEF, while Tempus ECG-Low EF analyzes 12-lead ECGs to identify signs of low LVEF. Therefore, their utility depends on the available diagnostic data and the specific type of heart failure being investigated.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is designed to analyze echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF). Tempus ECG-Low EF analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%), which is indicative of Heart Failure with reduced Ejection Fraction (HFrEF).
EchoGou00ae Heart Failure requires routine echocardiogram video clips for its analysis. Tempus ECG-Low EF utilizes resting, non-ambulatory 12-lead ECG recordings from patients 40 years or older at risk of heart failure.
EchoGou00ae Heart Failure delivers automated structured reports with insights within 20 minutes, integrating seamlessly with existing workflows and IT stacks, and delivering reports via DICOM to PACS. Tempus ECG-Low EF provides a binary output (Low LVEF Detected / Not Detected) and is integrated into healthcare facility workflows, but a specific turnaround time is not provided.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For Tempus ECG-Low EF, pricing information requires contacting the vendor directly.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. Tempus ECG-Low EF demonstrated a sensitivity of 86% and a specificity of 83% for classifying patients with low LVEF in its performance study.
EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS, and is cloud-deployed. Tempus ECG-Low EF is deployed as software integrated into healthcare facility workflows.
More Comparisons
Backers
Who funded each tool's parent company.